Utility of anakinra in acute crystalline diseases: A retrospective study comparing a university hospital with a veterans affairs medical center

Julianna Desmarais, Cong-Qiu Chu

Research output: Contribution to journalArticle

2 Scopus citations


Objective. To evaluate the efficacy and safety of anakinra in inpatient management of acute gout and pseudogout. Methods. Hospitalized patients with acute gout (n = 77) or pseudogout (n = 11) or both (n = 3) were analyzed for response to anakinra and adverse effects. Results. Half of all patients had comorbidities limiting the treatment choice. Anakinra was well tolerated, and 92% of gout flares and 79% of pseudogout flares responded to treatment. Conclusion. Anakinra is an effective and safe treatment for acute gout and pseudogout in hospitalized patients, particularly in those with comorbidities.

Original languageEnglish (US)
Pages (from-to)748-750
Number of pages3
JournalJournal of Rheumatology
Issue number7
Publication statusPublished - Jan 1 2019



  • Anakinra
  • Gout
  • Pseudogout

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this